Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.

https://doi.org/10.1182/hematology.2019000011

Published: 2019

Journal Articles

Where does transplant fit in the age of targeted therapies?

Victor A. Chow, Ajay K. Gopal

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 287–293.

https://doi.org/10.1182/hematology.2019000033

Published: 2019

Journal Articles

Genomics of aggressive B-cell lymphoma

Allison Rosenthal, Lisa Rimsza

Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 69–74.

https://doi.org/10.1182/asheducation-2018.1.69

Published: 2018

Journal Articles

Role of the microenvironment across histological subtypes of NHL

Karin Tarte

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 610–617.

https://doi.org/10.1182/asheducation-2017.1.610

Published: 2017

Journal Articles

Update in large cell lymphoma: understanding the pathology report

Eric D. Hsi

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 605–617.

https://doi.org/10.1182/asheducation-2015.1.605

Published: 2015

Journal Articles

Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC

Steven H. Swerdlow

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 90–99.

https://doi.org/10.1182/asheducation-2014.1.90

Published: 2014

Journal Articles

Impact of MYC on malignant behavior

German Ott

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 100–106.

https://doi.org/10.1182/asheducation-2014.1.100

Published: 2014

Journal Articles

Double-hit lymphomas: current paradigms and novel treatment approaches

Kieron Dunleavy

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 107–112.

https://doi.org/10.1182/asheducation-2014.1.107

Published: 2014

Journal Articles

Understanding MYC -driven aggressive B-cell lymphomas: pathogenesis and classification

German Ott, Andreas Rosenwald, Elias Campo

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 575–583.

https://doi.org/10.1182/asheducation-2013.1.575

Published: 2013

Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Michelle Fanale

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.

https://doi.org/10.1182/asheducation-2013.1.406

Published: 2013

Journal Articles

Targeting B-cell receptor signaling: changing the paradigm

Nathan Fowler, Eric Davis

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 553–560.

https://doi.org/10.1182/asheducation-2013.1.553

Published: 2013

Journal Articles

The many faces of marginal zone lymphoma

Pier Luigi Zinzani

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 426–432.

https://doi.org/10.1182/asheducation.V2012.1.426.3798535

Published: 2012

Journal Articles

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Adam Bagg

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 330–335.

https://doi.org/10.1182/asheducation-2011.1.330

Published: 2011

Journal Articles

Aggressive B-Cell Lymphomas: A Review of New and Old Entities in the WHO Classification

Elaine S. Jaffe, Stefania Pittaluga

Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 506–514.

https://doi.org/10.1182/asheducation-2011.1.506

Published: 2011

Journal Articles

Molecular biology of Hodgkin lymphoma

Ralf Küppers

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 491–496.

https://doi.org/10.1182/asheducation-2009.1.491

Published: 2009

Journal Articles

Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL

Brad Kahl, David Yang

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 359–364.

https://doi.org/10.1182/asheducation-2008.1.359

Published: 2008

Journal Articles

The Biology of the Germinal Center

Yasodha Natkunam

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 210–215.

https://doi.org/10.1182/asheducation-2007.1.210

Published: 2007

Journal Articles

Molecular Signatures Define New Rational Treatment Targets in Large B-Cell Lymphomas

Margaret A. Shipp

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 265–269.

https://doi.org/10.1182/asheducation-2007.1.265

Published: 2007

Journal Articles

Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond

Celeste Bello, Eduardo M. Sotomayor

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 233–242.

https://doi.org/10.1182/asheducation-2007.1.233

Published: 2007

Journal Articles

Vaccine Therapy for B-Cell Lymphomas: Next-Generation Strategies

Sattva S. Neelapu, Larry W. Kwak

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 243–249.

https://doi.org/10.1182/asheducation-2007.1.243

Published: 2007

NARROW

Molecular profiling and management of mantle cell lymphoma

Where does transplant fit in the age of targeted therapies?

Genomics of aggressive B-cell lymphoma

Role of the microenvironment across histological subtypes of NHL

Update in large cell lymphoma: understanding the pathology report

Diagnosis of ‘double hit’ diffuse large B-cell lymphoma and B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma: when and how, FISH versus IHC

Impact of MYC on malignant behavior

Double-hit lymphomas: current paradigms and novel treatment approaches

Understanding MYC -driven aggressive B-cell lymphomas: pathogenesis and classification

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Targeting B-cell receptor signaling: changing the paradigm

The many faces of marginal zone lymphoma

B Cells Behaving Badly: A Better Basis to Behold Belligerence in B-Cell Lymphomas

Aggressive B-Cell Lymphomas: A Review of New and Old Entities in the WHO Classification

Molecular biology of Hodgkin lymphoma

Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL

The Biology of the Germinal Center

Molecular Signatures Define New Rational Treatment Targets in Large B-Cell Lymphomas

Monoclonal Antibodies for B-Cell Lymphomas: Rituximab and Beyond

Vaccine Therapy for B-Cell Lymphomas: Next-Generation Strategies

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only